Darktrace lowered its pricing for the float from a rumoured £3 billion valuation, possibly influenced by concerns in the market about its connection to Dr Mike Lynch, the Autonomy founder facing US fraud charges. He denies the claims but his status as a founder investor in Darktrace and, until recently, an advisor to the firm, was said to be putting off some investors.